Warshaw Scholars

Dr. Prasanna Ananth is a pediatric hematologist/oncologist. As a specialist caring for children with cancer and blood disorders, she says that helping children and families cope with serious illness provides inspiration for her patient care and research. Dr. Ananth is an Assistant Professor of Pediatrics (Hematology/Oncology). Her research focuses on evaluating and improving care for children with advanced cancer. Watch a video with Dr. Prasanna Ananth >>

Paul Aronson is an Associate Professor of Pediatrics and of Emergency Medicine in the Section of Pediatric Emergency Medicine. His educational interests include teaching evidence-assisted medicine and engaging residents in scholarly activities, and he leads the Research Track for the residency program. His primary areas of research are the evaluation and management of the febrile young infant and shared decision-making with parents in the emergency department, and he is an investigator for several multicenter research networks. He enjoys any and all sports, focusing on Yale and Duke teams and the sports his son Eli and daughter Hayley play, particularly hockey and baseball. Mostly, he likes spending time with his wife and kids and exploring all that Connecticut has to offer.

Clifford W. Bogue, MD, a pediatric critical care specialist, is the Waldemar Von Zedtwitz Professor and Chairman of Pediatrics at Yale School of Medicine, where he has been on the faculty since 1993.  In 2014, he was also named the inaugural Chief Medical Officer of Yale-New Haven Children’s Hospital, where he provides strategic and operational leadership for the Children’s Hospital’s clinical delivery systems. Dr. Bogue was named Chairman of the Department of Pediatrics in August, 2017.  Dr. Bogue received both his undergraduate and medical degrees from the University of Virginia (UVA).  He was a resident and chief resident in pediatrics at Vanderbilt University before completing a fellowship in pediatric critical care medicine at Yale.During his career at Yale, Dr. Bogue has held a number of medical school and hospital leadership positions, including Director of Pediatric Critical Care Transport, Medical Director of the Pediatric Intensive Care Unit, Director of the Pediatric Critical Care Fellowship, Chief of Pediatric Critical Care Medicine and Associate Chairman for Strategic Planning. From 2010 – 2012, he served as Interim Chairman of Pediatrics and Physician-in-Chief of Yale New Haven Children’s Hospital and from 2012 – 2015 served as Vice Chairman of the Department of Pediatrics. He served as Interim Chairman of Pediatrics from 2015 – 2017.Dr. Bogue has been actively involved in training students, residents and fellows and is committed to the development of pediatric physician-scientists.  He was director of Bedside to Bench: Seminars in Pediatrics, a course for first-year medical students for over ten years, served on the MD/PhD Faculty Committee, was PI for an NIH T32 training program in cardiopulmonary development for 10 years. He most recently served as training director for the Yale Child Health Research Center, a K12 program funded by the NICHD that had 25 years of consecutive funding. He has served on several NIH peer review panels and is currently a member of the Child Health Research Scientific Review Committee of the Charles H. Hood Foundation.  He previously served as Co-Chair of the American Heart Association Genetics/Epigenetics peer review committee. In 2014, Dr. Bogue was the Chair of the Planning Committee for Pediatric Clinical Trials Network Stakeholders’ Forum, a forum convened by the American Academy of Pediatrics to initiate the process of developing a global pediatric clinical trials network. Dr. Bogue served on two NIH Advisory Committees of the NIH focused on the inclusion of children in research and in the Precision Medicine Program Initiative All of Us.Dr. Bogue’s academic career at Yale also included establishing and directing an NIH-funded research program in the developmental biology of the lung, liver and cardiovascular system for over 20 years.  During that time, his laboratory made important contributions to the genetic pathways involved in embryonic organ development, including the identification of genetic pathways critical to formation of the liver and biliary system as well as the cardiovascular system.Dr. Bogue has served on a number of national and international boards in academic pediatrics including the Council of the Society for Pediatric Research, the Federation of Pediatric Organizations’ Child Health Research and Training Workgroup, and the Program Committee of the Pediatric Academic Societies’ Meeting where he served as Chair from 2015 - 2017.  He is currently a Trustee and President of the International Pediatric Research Foundation (which is responsible for publishing the journal Pediatric Research), Secretary-Treasurer of the American Pediatric Society, Chair of the AAP Committee on Pediatric Research, and Section Editor for Current Opinion in Pediatrics. He has been named annually to Best Doctors in America since 2004 and was awarded both the Mae Gailani Young Investigator and Norman J Siegel Faculty Awards at the Yale School of Medicine.

Dr. Nina Brodsky is an Assistant Professor of Pediatrics in the Section of Critical Care Medicine at Yale University School of Medicine. She received her M.D. from the University of Maryland, completed her Pediatric residency training at The Children's Hospital at Montefiore, and her Pediatric Critical Care fellowship at Yale New Haven Children's Hospital. Her research interests include the genetic and environmental etiologies of immunodeficiency and pathologic inflammation, as well as signaling and mechanisms of disease in patients with these conditions. Dr. Brodsky is particularly interested in human T cell developmental immunology and regulation of inflammation in health and disease. Her goal is to uncover and develop targeted translational therapies to improve immune responses during vaccination, infection, and immune-mediated diseases.

Caty Buck is a neonatologist and clinical researcher. She completed her pediatric training at UTSW Medical Center in Dallas, Texas and her Neonatal-Perinatal Medicine fellowship at Women and Infant's Hospital and Brown Medical School. Her research is focused on understanding how maternal metabolic health in pregnancy and the early newborn period influence infant growth, body composition, and neurodevelopment.

Julie Flom, MD, MPH is an Assistant Professor of Pediatric Allergy and Immunology in the division of Pediatric Pulmonology, Allergy, Immunology & Sleep Medicine and specializes in treating children with allergic disorders and immunodeficiencies. Dr. Flom earned her medical degree at the New York University School of Medicine and her MPH from the Mailman School of Public Health at Columbia University. She completed her pediatric residency training and her allergy and immunology fellowship at the Icahn School of Medicine at Mount Sinai. Dr. Flom’s clinical and research interests include understanding early life risk factors and underlying mechanisms for development of pediatric allergic diseases including food allergy, asthma, eczema, and environmental allergies, and applications to prevention and treatment of allergic disease.

Dr. Gaither is an Assistant Professor of Pediatrics (General Pediatrics) and Public Health (Chronic Disease Epidemiology). She obtained her doctorate in epidemiology from the Yale School of Public Health in 2015. After completing a post-doctoral fellowship in bioinformatics, she joined the faculty of the Yale School of Medicine in the Department of Pediatrics. Her research focuses on the impact of the opioid crisis on vulnerable populations, work she began more than a decade ago as part of her dissertation research, for which she received a National Research Service Award from the NIH to study the association between opioid prescribing practices and all-cause mortality among U.S. veterans. In 2015, she began working on a project that allowed her to bridge her interests in adult medicine with that of pediatrics, which resulted in the first national publication to examine hospitalizations for opioid poisonings in children. She followed this work with the first national study to examine pediatric deaths from opioids. Prior to these publications, most of what was known about opioid-related morbidity and mortality came from the adult overdose literature. To date, she has published 56 papers in peer-reviewed journals and her research has been supported by awards from the National Institute on Drug Abuse (NIDA), the National Center for Advancing Translational Science, the Patterson Trust, the Hood Foundation, and most recently, the National Institute for Child Health and Human Development (NICHD).

Dr. Greenberg grew up in New York, before attending Cornell University to study Biological Engineering. He then attended medical school at the State University of New York at Brooklyn. He completed his residency in Pediatrics at New York University Medical Center. Dr. Greenberg completed his fellowship in Pediatric Nephrology at the Yale University School of Medicine. He also obtained a Masters degree from Yale in Health Sciences Research . Dr. Greenberg is now an Assistant Professor of Pediatrics in the Section of Nephrology at Yale University and a clinical investigator in the Clinical and Translational Research Accelerator (CTRA). His research focuses on improving risk prediction to assist with clinical decision making and inform clinical trials in children with kidney disease.

Abha R. Gupta obtained her BS in Molecular Biophysics and Biochemistry from Yale University. She earned her MD and PhD (Neuroscience) degrees at the University of Pennsylvania. She completed a residency in general pediatrics at the Children's Hospital of Philadelphia (CHOP) and a clinical fellowship in Developmental-Behavioral Pediatrics at CHOP and Yale School of Medicine. Her clinical and research interests are in autism spectrum disorder (ASD), especially regressive conditions such as childhood disintegrative disorder (CDD). She obtained postdoctoral research training in the genetic investigation of ASD. As a principal investigator, she is pursuing both the genetics and neurobiology (stem cell modeling) of ASD.

Kimberly Hieftje, PhD, is an Assistant Professor at Yale Pediatrics and co-director/co-founder of XRPeds and the Yale Center for Immersive Technologies in Pediatrics, which focuses on the development and evaluation of videogame interventions using extended reality (virtual reality, augmented reality, etc) for health prevention and promotion, behavior change, and education in adolescents and young adults. She is currently involved in the development and testing of several health behavior change XR and game-based interventions and has published frequently on developing, evaluating, and implementing serious games. She has worked on games that have focused on topics including vaping/e-c-cigarette prevention, tobacco use prevention, risk reduction in adolescents, HIV/STI prevention, HIV/STI testing, empowering girls around healthy decision making, bystander intervention, LGBTQ bullying, school climate, and alcohol harm reduction. Dr. Hieftje was a K12 Scholar in the Yale Implementation Science program (YSIS), where she focused on understanding the factors associated with successful implementation of videogame interventions in schools. Dr. Hieftje is also the editor-in-chief at the Games for Health Journal.

Dr. Konnikova's team focuses on the development of early life immunity particularly at barrier sites such as the GI tract and the maternal-fetal interface with a particular focus on T cell biology. Using multi-omic approaches, the group investigates how mucosal homeostasis is developed and what contributes to pathogenesis of diverse diseases such as sepsis, preterm labor, necrotizing enterocolitis (NEC), very early onset (VEO) and pediatric IBD. The Konnikova lab is further interested in how the microbiome and the associated metabolome regulate immune development and homeostasis at barrier sites. Her group is also interested in how early life events alter circulating immune cells. To this end, in collaboration with the NOuRISH team they are enrolling infants in a longitudinal study of peripheral blood development.

Alice graduated from Cornell University with a double major in Biological Sciences (Molecular & Cell Biology) and Biology & Society (Public Policy). Her undergraduate research investigated the kinetics of retroviral assembly and budding in the laboratory of Professor Volker Vogt. Following graduation, she was a Fulbright Scholar at the University of Melbourne in Australia, where she studied the developmental processes of T cell selection with Professor Stephen J. Turner and Nobel Laureate Professor Peter C. Doherty.Alice is currently an MD-PhD student at Yale performing her dissertation research in the laboratory of Professor Akiko Iwasaki. She is investigating the impact of maternal antiviral responses on fetal development during pregnancy.

Dr. Makhani completed her child neurology training and a formal multiple sclerosis fellowship at the Hospital for Sick Children and the University of Toronto. She also completed a Masters' Degree in Public Health at the Harvard School of Public Health. Dr. Makhani's clinical and research interests are in pediatric multiple sclerosis and other childhood brain inflammatory diseases. She is funded by NIH and the Charles H Hood Foundation to carry out studies to determine risk factors for clinical multiple sclerosis in asymptomatic children with brain MRI findings suggestive of multiple sclerosis.

Dr. Thomas Murray is a Professor at the Yale University School of Medicine in the Department of Pediatrics, Section of Infectious Disease where he serves as the Fellowship Director and the Associate Medical Director for Infection Prevention at Yale New Haven Children's Hospital. He is also the Medical Director of the Winchester Pediatric Tuberculosis Clinic. After receiving his MD and PhD from the University of Connecticut, he completed pediatric residency at Yale New Haven Hospital. He remained at Yale, completing fellowships in both pediatric infectious diseases and medical microbiology and returned to the faculty of the Yale Medical School in 2018. He studies infection prevention and disinfection in the healthcare and home environment as well as host pathogen interactions during pulmonary infections with an emphasis on children with Cystic Fibrosis

Dr. Oluwabunmi (Bunmi) Olaloye is an Instructor of Pediatrics in the Division of Neonatology. She received her M.D. from Rutgers New Jersey Medical School, completed her residency in Pediatrics at the University of Texas Medical Branch in Galveston, and her neonatology fellowship at the University of Pittsburgh Medical Center, Children’s Hospital of Pittsburgh. Her research interests include deciphering the role of immune dysfunction in necrotizing enterocolitis to identify biomarkers and therapeutic targets. Her research explores immune-epithelial interactions in the pathogenesis of neonatal spontaneous intestinal perforation using deep immunophenotyping of human tissue

Dr. Carlos Oliveira is an attending physician and specialist in pediatric infectious diseases at Yale New Haven Children's Hospital. He is Board Certified in General Pediatrics, Pediatric Infectious Diseases, and Clinical Informatics and serves on the faculty at both Yale School of Medicine and Yale School of Public Health as an Assistant Professor of Pediatrics (Infectious Diseases & Global Health), of Biostatistics (Health Informatics), and of Biomedical Informatics & Data Science. Dr. Oliveira serves as the Director for Yale’s clinical programs in Pediatric HIV/AIDS, Congenital Infectious Diseases, and Pediatric COVID-19. Dr. Oliveira leads a research group that pursues quantitative, experimental, and field research centered around various aspects of vaccinology and epidemiology of perinatal/neonatal infections.